查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873370

临床试验影像：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 129 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球临床试验诊断影像市场规模估计为 15.79 亿美元，预计到 2031 年将达到 25.01 亿美元，2025 年至 2031 年的复合年增长率为 6.9%。

临床试验影像学是指在临床试验过程中，利用X光、CT扫描和MRI扫描等影像技术观察分析受试者体内状况的过程。它在评估新药、治疗方法和医疗设备的疗效、安全性和副作用方面发挥着不可替代的作用。影像技术使研究人员能够直观地观察药物在体内的分布、代谢和作用机制，为药物的临床应用提供科学基础。

全球领先的临床试验影像设备製造商包括Clario、ICON、MacLaren、Calix和BioTelemetry。前五大公司占据了约60%的市场。北美市占率最大，约33%，其次是欧洲和亚太地区，各占约27%。依产品类型划分，中心影像服务是最大的细分市场，约占70%的市场。按应用领域划分，製药公司是最大的用户，其次是生技公司。

临床试验影像检查流程必须严格遵守伦理原则和监管要求。研究者必须确保受试者的知情同意权得到充分保障，并在试验过程中严格遵循科学原则和伦理标准。同时，监管机构必须加强对临床试验影像检查的监管，以确保试验结果的可靠性和有效性。

临床试验影像在药物研发的不同阶段都扮演着重要角色。例如，在I期临床试验中，影像技术可用于观察药物在体内的药物动力学特性。在II/III期临床试验中，则可用于评估药物的疗效和安全性。

对于新型医疗设备，临床试验影像可用于评估其性能、安全性和临床应用价值。将新型器材的有效性与现有器材进行比较，可以为医疗设备的推广和应用提供强而有力的支援。

在临床试验中，影像技术也用于早期诊断、后续观察和疗效评估。例如，在肿瘤治疗中，定期影像检查可以观察肿瘤的大小、形态和变化，从而及时调整治疗方案。

随着医疗技术的不断进步和临床试验需求的日益增长，临床试验影像诊断市场预计将迎来更广阔的发展前景。未来，该领域可望更加重视技术创新和个人化服务的开发，以满足各类临床试验的需求。

临床试验影像市场的主要驱动因素包括：

技术进步：创新驱动核心成长

高精度、多模态诊断影像技术

MRI、CT 和 PET 等技术突破：高解析度成像技术（如 3T MRI 和超低剂量 CT）提供更准确的解剖和功能信息，有助于更早诊断疾病和评估疗效。

多模态融合：CT-MRI 和 PET-CT 融合技术结合了解剖和代谢讯息，显着提高了诊断敏感性，例如在肿瘤分期中。

人工智慧与自动化

人工智慧辅助分析：深度学习演算法可自动侦测病灶（例如肺结节和乳房钙化），从而减少人为错误并提高诊断效率。

流程自动化：人工智慧驱动的扫描通讯协定最佳化和自动报告产生可缩短临床试验週期并降低成本。

携带式即时诊断成像

携带式超音波设备：适用于床边检查和偏远地区，扩大了临床试验的范围。

即时成像技术，例如超音波弹性成像，可以动态监测组织硬度的变化，并为肝纤维化等疾病提供即时回馈。

政策支持：营造有利的发展环境

完善法规结构

FDA 和 NMPA 等机构：透过严格的核准程序确保设备的安全性和有效性（例如，III 类医疗影像设备在註册前必须经过临床试验）。

国际标准的协调：促进影像通讯协定和资料标准化（例如 DICOM 格式），以促进多中心研究资料的共用。

资金和奖励

政府科研经费：例如，中国的「十四五」规划为加速医学影像技术的科技转型提供了专案支援。

税收优惠和补贴：为鼓励企业进行研发和创新，将提供财政补贴，例如，对在国内生产高端诊断成像设备的计划提供补贴。

医疗需求成长：人口结构与疾病结构的变化

老化与慢性病负担

癌症和神经退化性疾病发生率高：全球癌症发生率不断上升，推动了对早期筛检和治疗反应监测的需求。

对精准医疗的需求：个人化治疗依赖高精度影像（例如，用于标靶治疗的分子影像）。

扩大新药研发与临床试验

创新药物研发蓬勃发展：全球正在研发的新药数量呈现爆炸性成长，带动了临床试验中影像需求的相应增加。

罕见疾病和真实世界研究：影像技术支援小规模样本试验和长期疗效追踪。

临床试验影像市场的成长受到技术创新、政策影响、日益精细化的需求以及不断演变的竞争格局的驱动。展望未来，人工智慧、多模态成像和云端技术的深度融合将加速市场朝向更高智慧化和精准化方向发展。同时，当地企业的崛起有望重塑全球竞争格局，并为产业注入新的活力。

本报告旨在对全球临床试验影像市场进行全面分析，重点关注总收入、市场份额和主要企业的排名，并按地区/国家、类型和应用对临床试验影像进行分析。

本报告以收益为准，以2024年为基准年，对临床试验影像市场规模、估算和预测进行了阐述，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析旨在帮助读者制定业务和成长策略，评估竞争格局，分析公司在当前市场中的地位，并就临床试验影像相关事宜做出明智的商业决策。

市场区隔

公司

  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO
  • Tigermed
  • Runda Medical
  • Konica Minolta
  • Keosys

按类型分類的细分市场

  • 内部图像服务
  • 中央图像服务

应用领域

  • 製药公司
  • 生技公司
  • 学术机构
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Clinical Trial Imaging was estimated to be worth US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:

Technological progress: innovation drives core growth

High-precision and multimodal imaging technology

Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation

AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging

Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment

Improvement of regulatory framework

FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives

Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure

Aging and chronic disease burden

High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion

Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Imaging by region & country, by Type, and by Application.

The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.

Market Segmentation

By Company

  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO
  • Tigermed
  • Runda Medical
  • Konica Minolta
  • Keosys

Segment by Type

  • In-house Imaging Service
  • Central Imaging Service

Segment by Application

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Imaging Product Introduction
  • 1.2 Global Clinical Trial Imaging Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Imaging Market Trends & Drivers
    • 1.3.1 Clinical Trial Imaging Industry Trends
    • 1.3.2 Clinical Trial Imaging Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Imaging Market Challenges
    • 1.3.4 Clinical Trial Imaging Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Imaging Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Imaging Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Imaging Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Imaging
  • 2.6 Clinical Trial Imaging Market Competitive Analysis
    • 2.6.1 Clinical Trial Imaging Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Imaging Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 In-house Imaging Service
    • 3.1.2 Central Imaging Service
  • 3.2 Global Clinical Trial Imaging Sales Value by Type
    • 3.2.1 Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Imaging Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Imaging Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical Companies
    • 4.1.2 Biotechnology Companies
    • 4.1.3 Academic Institutes
    • 4.1.4 Others
  • 4.2 Global Clinical Trial Imaging Sales Value by Application
    • 4.2.1 Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Imaging Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Imaging Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Imaging Sales Value by Region
    • 5.1.1 Global Clinical Trial Imaging Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Imaging Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Imaging Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Imaging Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Imaging Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Imaging Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Imaging Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Imaging Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Imaging Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Imaging Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Imaging Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Imaging Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Imaging Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Imaging Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Imaging Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 ICON
    • 7.1.1 ICON Profile
    • 7.1.2 ICON Main Business
    • 7.1.3 ICON Clinical Trial Imaging Products, Services and Solutions
    • 7.1.4 ICON Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.1.5 ICON Recent Developments
  • 7.2 ERT
    • 7.2.1 ERT Profile
    • 7.2.2 ERT Main Business
    • 7.2.3 ERT Clinical Trial Imaging Products, Services and Solutions
    • 7.2.4 ERT Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.2.5 ERT Recent Developments
  • 7.3 McLaren
    • 7.3.1 McLaren Profile
    • 7.3.2 McLaren Main Business
    • 7.3.3 McLaren Clinical Trial Imaging Products, Services and Solutions
    • 7.3.4 McLaren Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.3.5 McLaren Recent Developments
  • 7.4 Bioclinica
    • 7.4.1 Bioclinica Profile
    • 7.4.2 Bioclinica Main Business
    • 7.4.3 Bioclinica Clinical Trial Imaging Products, Services and Solutions
    • 7.4.4 Bioclinica Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Bioclinica Recent Developments
  • 7.5 Parexel
    • 7.5.1 Parexel Profile
    • 7.5.2 Parexel Main Business
    • 7.5.3 Parexel Clinical Trial Imaging Products, Services and Solutions
    • 7.5.4 Parexel Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Parexel Recent Developments
  • 7.6 BioTelemetry
    • 7.6.1 BioTelemetry Profile
    • 7.6.2 BioTelemetry Main Business
    • 7.6.3 BioTelemetry Clinical Trial Imaging Products, Services and Solutions
    • 7.6.4 BioTelemetry Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.6.5 BioTelemetry Recent Developments
  • 7.7 ProScan Imaging
    • 7.7.1 ProScan Imaging Profile
    • 7.7.2 ProScan Imaging Main Business
    • 7.7.3 ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
    • 7.7.4 ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.7.5 ProScan Imaging Recent Developments
  • 7.8 Imaging Endpoints
    • 7.8.1 Imaging Endpoints Profile
    • 7.8.2 Imaging Endpoints Main Business
    • 7.8.3 Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
    • 7.8.4 Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Imaging Endpoints Recent Developments
  • 7.9 Radiant Sage
    • 7.9.1 Radiant Sage Profile
    • 7.9.2 Radiant Sage Main Business
    • 7.9.3 Radiant Sage Clinical Trial Imaging Products, Services and Solutions
    • 7.9.4 Radiant Sage Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Radiant Sage Recent Developments
  • 7.10 Micron, Inc.
    • 7.10.1 Micron, Inc. Profile
    • 7.10.2 Micron, Inc. Main Business
    • 7.10.3 Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
    • 7.10.4 Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Micron, Inc. Recent Developments
  • 7.11 Intrinsic Imaging
    • 7.11.1 Intrinsic Imaging Profile
    • 7.11.2 Intrinsic Imaging Main Business
    • 7.11.3 Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
    • 7.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Intrinsic Imaging Recent Developments
  • 7.12 Median Technologies
    • 7.12.1 Median Technologies Profile
    • 7.12.2 Median Technologies Main Business
    • 7.12.3 Median Technologies Clinical Trial Imaging Products, Services and Solutions
    • 7.12.4 Median Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Median Technologies Recent Developments
  • 7.13 Cardiovascular Imaging Technologies
    • 7.13.1 Cardiovascular Imaging Technologies Profile
    • 7.13.2 Cardiovascular Imaging Technologies Main Business
    • 7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
    • 7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Cardiovascular Imaging Technologies Recent Developments
  • 7.14 Banook Medical
    • 7.14.1 Banook Medical Profile
    • 7.14.2 Banook Medical Main Business
    • 7.14.3 Banook Medical Clinical Trial Imaging Products, Services and Solutions
    • 7.14.4 Banook Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Banook Medical Recent Developments
  • 7.15 IXICO
    • 7.15.1 IXICO Profile
    • 7.15.2 IXICO Main Business
    • 7.15.3 IXICO Clinical Trial Imaging Products, Services and Solutions
    • 7.15.4 IXICO Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.15.5 IXICO Recent Developments
  • 7.16 Tigermed
    • 7.16.1 Tigermed Profile
    • 7.16.2 Tigermed Main Business
    • 7.16.3 Tigermed Clinical Trial Imaging Products, Services and Solutions
    • 7.16.4 Tigermed Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Tigermed Recent Developments
  • 7.17 Runda Medical
    • 7.17.1 Runda Medical Profile
    • 7.17.2 Runda Medical Main Business
    • 7.17.3 Runda Medical Clinical Trial Imaging Products, Services and Solutions
    • 7.17.4 Runda Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Runda Medical Recent Developments
  • 7.18 Konica Minolta
    • 7.18.1 Konica Minolta Profile
    • 7.18.2 Konica Minolta Main Business
    • 7.18.3 Konica Minolta Clinical Trial Imaging Products, Services and Solutions
    • 7.18.4 Konica Minolta Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Konica Minolta Recent Developments
  • 7.19 Keosys
    • 7.19.1 Keosys Profile
    • 7.19.2 Keosys Main Business
    • 7.19.3 Keosys Clinical Trial Imaging Products, Services and Solutions
    • 7.19.4 Keosys Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Keosys Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Imaging Industrial Chain
  • 8.2 Clinical Trial Imaging Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Imaging Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Imaging Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Imaging Market Trends
  • Table 2. Clinical Trial Imaging Market Drivers & Opportunity
  • Table 3. Clinical Trial Imaging Market Challenges
  • Table 4. Clinical Trial Imaging Market Restraints
  • Table 5. Global Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Imaging Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Imaging Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Imaging
  • Table 10. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Imaging Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Imaging Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Imaging Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Imaging Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Imaging Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Imaging Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Imaging Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Imaging Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Imaging Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Imaging Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Imaging Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Imaging Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Imaging Sales Value, (2026-2031) & (US$ Million)
  • Table 31. ICON Basic Information List
  • Table 32. ICON Description and Business Overview
  • Table 33. ICON Clinical Trial Imaging Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Imaging Business of ICON (2020-2025)
  • Table 35. ICON Recent Developments
  • Table 36. ERT Basic Information List
  • Table 37. ERT Description and Business Overview
  • Table 38. ERT Clinical Trial Imaging Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Imaging Business of ERT (2020-2025)
  • Table 40. ERT Recent Developments
  • Table 41. McLaren Basic Information List
  • Table 42. McLaren Description and Business Overview
  • Table 43. McLaren Clinical Trial Imaging Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Imaging Business of McLaren (2020-2025)
  • Table 45. McLaren Recent Developments
  • Table 46. Bioclinica Basic Information List
  • Table 47. Bioclinica Description and Business Overview
  • Table 48. Bioclinica Clinical Trial Imaging Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Imaging Business of Bioclinica (2020-2025)
  • Table 50. Bioclinica Recent Developments
  • Table 51. Parexel Basic Information List
  • Table 52. Parexel Description and Business Overview
  • Table 53. Parexel Clinical Trial Imaging Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Imaging Business of Parexel (2020-2025)
  • Table 55. Parexel Recent Developments
  • Table 56. BioTelemetry Basic Information List
  • Table 57. BioTelemetry Description and Business Overview
  • Table 58. BioTelemetry Clinical Trial Imaging Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Imaging Business of BioTelemetry (2020-2025)
  • Table 60. BioTelemetry Recent Developments
  • Table 61. ProScan Imaging Basic Information List
  • Table 62. ProScan Imaging Description and Business Overview
  • Table 63. ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Imaging Business of ProScan Imaging (2020-2025)
  • Table 65. ProScan Imaging Recent Developments
  • Table 66. Imaging Endpoints Basic Information List
  • Table 67. Imaging Endpoints Description and Business Overview
  • Table 68. Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Imaging Business of Imaging Endpoints (2020-2025)
  • Table 70. Imaging Endpoints Recent Developments
  • Table 71. Radiant Sage Basic Information List
  • Table 72. Radiant Sage Description and Business Overview
  • Table 73. Radiant Sage Clinical Trial Imaging Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Imaging Business of Radiant Sage (2020-2025)
  • Table 75. Radiant Sage Recent Developments
  • Table 76. Micron, Inc. Basic Information List
  • Table 77. Micron, Inc. Description and Business Overview
  • Table 78. Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Imaging Business of Micron, Inc. (2020-2025)
  • Table 80. Micron, Inc. Recent Developments
  • Table 81. Intrinsic Imaging Basic Information List
  • Table 82. Intrinsic Imaging Description and Business Overview
  • Table 83. Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Imaging Business of Intrinsic Imaging (2020-2025)
  • Table 85. Intrinsic Imaging Recent Developments
  • Table 86. Median Technologies Basic Information List
  • Table 87. Median Technologies Description and Business Overview
  • Table 88. Median Technologies Clinical Trial Imaging Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Clinical Trial Imaging Business of Median Technologies (2020-2025)
  • Table 90. Median Technologies Recent Developments
  • Table 91. Cardiovascular Imaging Technologies Basic Information List
  • Table 92. Cardiovascular Imaging Technologies Description and Business Overview
  • Table 93. Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Clinical Trial Imaging Business of Cardiovascular Imaging Technologies (2020-2025)
  • Table 95. Cardiovascular Imaging Technologies Recent Developments
  • Table 96. Banook Medical Basic Information List
  • Table 97. Banook Medical Description and Business Overview
  • Table 98. Banook Medical Clinical Trial Imaging Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Clinical Trial Imaging Business of Banook Medical (2020-2025)
  • Table 100. Banook Medical Recent Developments
  • Table 101. IXICO Basic Information List
  • Table 102. IXICO Description and Business Overview
  • Table 103. IXICO Clinical Trial Imaging Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Clinical Trial Imaging Business of IXICO (2020-2025)
  • Table 105. IXICO Recent Developments
  • Table 106. Tigermed Basic Information List
  • Table 107. Tigermed Description and Business Overview
  • Table 108. Tigermed Clinical Trial Imaging Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Clinical Trial Imaging Business of Tigermed (2020-2025)
  • Table 110. Tigermed Recent Developments
  • Table 111. Runda Medical Basic Information List
  • Table 112. Runda Medical Description and Business Overview
  • Table 113. Runda Medical Clinical Trial Imaging Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Clinical Trial Imaging Business of Runda Medical (2020-2025)
  • Table 115. Runda Medical Recent Developments
  • Table 116. Konica Minolta Basic Information List
  • Table 117. Konica Minolta Description and Business Overview
  • Table 118. Konica Minolta Clinical Trial Imaging Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Clinical Trial Imaging Business of Konica Minolta (2020-2025)
  • Table 120. Konica Minolta Recent Developments
  • Table 121. Keosys Basic Information List
  • Table 122. Keosys Description and Business Overview
  • Table 123. Keosys Clinical Trial Imaging Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Clinical Trial Imaging Business of Keosys (2020-2025)
  • Table 125. Keosys Recent Developments
  • Table 126. Key Raw Materials Lists
  • Table 127. Raw Materials Key Suppliers Lists
  • Table 128. Clinical Trial Imaging Downstream Customers
  • Table 129. Clinical Trial Imaging Distributors List
  • Table 130. Research Programs/Design for This Report
  • Table 131. Key Data Information from Secondary Sources
  • Table 132. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Imaging Product Picture
  • Figure 2. Global Clinical Trial Imaging Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Imaging Report Years Considered
  • Figure 5. Global Clinical Trial Imaging Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Imaging Revenue in 2024
  • Figure 7. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. In-house Imaging Service Picture
  • Figure 9. Central Imaging Service Picture
  • Figure 10. Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Clinical Trial Imaging Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Pharmaceutical Companies
  • Figure 13. Product Picture of Biotechnology Companies
  • Figure 14. Product Picture of Academic Institutes
  • Figure 15. Product Picture of Others
  • Figure 16. Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Clinical Trial Imaging Sales Value Market Share by Application, 2024 & 2031
  • Figure 18. North America Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Clinical Trial Imaging Sales Value (%), (2020-2031)
  • Figure 29. United States Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 31. United States Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 32. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 34. Europe Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 35. China Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 37. China Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 38. Japan Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Japan Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 41. South Korea Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 43. South Korea Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Southeast Asia Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Southeast Asia Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 47. India Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 49. India Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Clinical Trial Imaging Industrial Chain
  • Figure 51. Clinical Trial Imaging Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed